- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Finjan Receives 3 Favorable Final Written PTAB Decisions
Finjan Holdings (NASDAQ:FNJN) reported that on March 16 and 17, 2017, the Patent Trial and Appeal Board for the United States Patent & Trademark Office ruled against Palo Alto Networks petitions for three Inter Partes Reviews. As quoted in the press release: Case No. IPR2015-01974 challenged Finjan’s U.S. Patent 7,647,633 and Case Nos. IPR2015-02001 and …
Finjan Holdings (NASDAQ:FNJN) reported that on March 16 and 17, 2017, the Patent Trial and Appeal Board for the United States Patent & Trademark Office ruled against Palo Alto Networks petitions for three Inter Partes Reviews.
As quoted in the press release:
Case No. IPR2015-01974 challenged Finjan’s U.S. Patent 7,647,633 and Case Nos. IPR2015-02001 and IPR2016-00157 challenged Finjan’s U.S. Patent 8,225,408. Blue Coat Systems, Inc. (“Blue Coat”) joined all three of these petitions so these PTAB decisions apply to its challenges as well.
In IPR2015-01974, the PTAB instituted a review on only two of the twelve challenged claims against the ‘633 Patent and, as a whole, found all challenged claims valid and patentable. In IPR2015-02001 and IPR2016-00157, the PTAB consolidated the petitions and instituted a review on twenty claims of the ‘408 Patent and, once again, found all challenged claims to be both valid and patentable.
Outlook Reports
Featured Cyber Security Investing Stocks
Browse Companies
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 2381.91 | +1.99 | |
Silver | 28.28 | +0.05 | |
Copper | 4.50 | +0.03 | |
Oil | 82.14 | -0.59 | |
Heating Oil | 2.53 | -0.01 | |
Natural Gas | 1.74 | -0.01 |
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.